Navigation Links
Barr Confirms Patent Challenge of Entocort(R), 3mg Enteric Coated Capsules
Date:5/27/2008

MONTVALE, N.J., May 27 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by AstraZeneca LP in connection with its Entocort(R) Enteric Coated Capsules (budesonide), 3mg. The Company believes that it is the first to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for Entocort EC.

Barr filed its ANDA containing a paragraph IV certification for a generic Entocort EC product with the U.S. Food & Drug Administration (FDA) in January 2008. Following receipt of the notice from the FDA that Barr's ANDA had been accepted for filing, Barr notified the New Drug Application (NDA) and patent holder.

On May 22, 2008, AstraZeneca filed suit in the U.S. District Court for the District of Delaware to prevent Barr from proceeding with the commercialization of its product. This action formally initiates the patent challenge process under the Hatch-Waxman Act.

Entocort EC (budesonide) had annual sales of approximately $125 million in the U.S., based on IMS sales data for the twelve-month period ending March 2008.

About Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 27 proprietary produ
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd.
2. Two Year Study Confirms SUPPRELIN(R) LA Implant Maintains Profound Suppression of Hormones in Children With Premature Onset Puberty
3. Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients
4. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
5. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
6. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
7. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
8. Barr Confirms Patent Challenge of Avodart(R) Soft Gelatin Capsules, 0.5mg
9. Icahn Confirms Intention to Nominate Three Directors at Biogen
10. Barr Confirms Patent Challenge of Namenda(R) Tablets, 5mg & 10mg
11. Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 Hussey Copper ... MD-Cu 29 antimicrobial copper announces Pullman Regional Hospital,s ... first EPA-registered antimicrobial solid touch surface, at a nominal ... of MRSA, E-coli and other bacteria within 2 hours of ... protecting against bacteria and infectious diseases in its facilities. ...
(Date:7/22/2014)... Md. , July 22, 2014  United ... today that it will release its second quarter ... July 29, 2014. United Therapeutics will ... 2014, at 9:00 a.m. Eastern Time.  The teleconference ... dialing 1-970-315-0533.  A rebroadcast of the teleconference will ...
(Date:7/22/2014)... 2014 Dr. Williams says, “Bush has ... recognized that the greatest health care system in the ... needlessly deadly while trying to serve the public. Unfortunately, ... to transform an enormous system that none of them ... his continuing series of Open Letters ( http://is.gd/wdU2CM ) ...
(Date:7/21/2014)... The yield so far is small, but chemists ... solution-based mineral substitution process to make a precursor to ... and alternative energy devices. , A paper describing the ... 21 issue of the journal Inorganic Chemistry , ... inorganic and nuclear chemistry fields. The paper was chosen ...
Breaking Biology Technology:Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2Oregon chemists eye improved thin films with metal substitution 2
... 4 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic Products, Inc. (OTC Bulletin ... leading plasma-based pharmaceutical companies in the,People,s Republic of ... it,s common stock was approved for quotation on ... Financial Industry,Regulatory Authority (FINRA)., "We are pleased ...
... 4 ,Cord Blood America, Inc. (OTC Bulletin Board: ... ( http://www.cordblood-america.com ),focused on bringing the life ... internationally, today announced its wholly owned,subsidiary, RainMakers International, ... at the Sunday, March 2, NASCAR UAW-Dodge 400 ...
... Continues to Draw Accolades from ... Cedars-Sinai Medical Community, LOS ... its sixth anniversary this month and announced,that it has 60 ... researchers at Cedars-Sinai Medical Center. These,researchers are active in areas ...
Cached Biology Technology:China Biologic Products Commences Trading on OTC Bulletin Board 2Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race 2Cord Blood America Subsidiary Featured at NASCAR Sprint Cup Series Race 3Winnick Family Clinical Research Center Celebrates 6th Anniversary 2
(Date:7/22/2014)... A research team from the National Institute of ... Clinic, has demonstrated a dramatically improved technique for ... molecular vibration "signatures." The new NIST technique is ... Raman spectroscopy, but one that delivers signals that ... Raman scattering, and 100 times stronger than obtained ...
(Date:7/22/2014)... in modifying properties of nanomaterials for application in devices ... recent innovative studies conducted by scientists from the National ... a simple, efficient and low cost technique involving a ... Professor Sow Chorng Haur from the Department of Physics ... properties of two different types of materials can be ...
(Date:7/22/2014)... hear that drinking milk helps make their bones strong or that ... the idea that if something is good for us, it must ... Journal of Consumer Research , when children hear about the benefits ... predicted that when food is presented to children as making them ... learning how to read or count, they would conclude the food ...
Breaking Biology News(10 mins):Enhanced NIST instrument enables high-speed chemical imaging of tissues 2Enhanced NIST instrument enables high-speed chemical imaging of tissues 3NUS scientists use low cost technique to improve properties and functions of nanomaterials 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 3
... crop that plays a key role in sustaining food security ... of the world, particularly drought-prone regions, it plays a central ... of people in Africa and Asia. To meet the ... desirable traits, such as higher yield and quality, disease resistance, ...
... to treat nausea and motion sickness, has the potential for new ... according to Dr. Vishal M. Gohil, Texas A&M AgriLife Research biochemist. ... drug has many potential new applications," Gohil said. "And now that ... to explore ways of using it to treat other diseases. We ...
... Boston University School of Medicine (BUSM) suggests that epigenetics may ... relapse of cancer. The findings are published online in Volume ... The term epigenetics refers to the external modifications ... do not change the DNA sequence, but instead, they affect ...
Cached Biology News:2 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 22 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 32 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 42 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 52 grants to UC Riverside boost scientists' efforts in developing improved cowpea varieties 6Old drug may teach new tricks in treating infectious diseases, cancer 2Old drug may teach new tricks in treating infectious diseases, cancer 3BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy 2